CDNA
CareDx, Inc.
+0.77 (+1.44%)54.32USD338K成交股數2.8B市值26.2本益比(近四季)6.1股價營收比+52.2%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 132M+52% | 118M+39% | 108M+31% | 100M+8% | 86.7M+20% | 84.7M+29% | 82.9M+23% | 92.3M+31% | 72.0M | 65.6M | 67.2M | 70.3M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 22.4M | 21.4M | 19.3M | 16.8M | 16.8M | 18.5M | 17.5M | 19.7M | 18.7M | 18.8M | 19.0M | 20.2M |
| 銷售管理費用 | 40.9M | 30.5M | 28.7M | 28.4M | 27.7M | 22.8M | 31.7M | 30.9M | 30.1M | 27.5M | 34.0M | 29.3M |
| 營業利益 | 113M-1118% | 1.2M-109% | −6.0M-56% | −246K-97% | −11.1M-51% | −13.4M-89% | −13.7M-52% | −7.3M-73% | −22.6M | −123M | −28.8M | −27.6M |
| 營業利益率 | 85.8% | 1.0% | -5.6% | -0.2% | -12.8% | -15.8% | -16.6% | -7.9% | -31.3% | -187.0% | -42.8% | -39.3% |
| 稅後淨利 | 111M-1391% | 2.8M-127% | −4.1M-61% | 1.7M-136% | −8.6M-57% | −10.4M-91% | −10.6M-55% | −4.6M-81% | −19.9M | −118M | −23.5M | −25.0M |
| 淨利率 | 83.8% | 2.4% | -3.8% | 1.7% | -9.9% | -12.2% | -12.8% | -5.0% | -27.6% | -180.1% | -35.0% | -35.5% |
| 稀釋 EPS | 2.07-1394% | 0.05-126% | -0.08-60% | 0.03-133% | -0.16-58% | -0.19-91% | -0.20-53% | -0.09-80% | -0.38 | -2.21 | -0.43 | -0.46 |
| 稀釋股數 | 53.4M | 53.1M | 53.3M | 53.7M | 54.3M | 55.3M | 52.9M | 52.2M | 51.7M | 53.8M | 54.2M | 53.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 374M | 77.9M | 65.4M | 91.4M | 68.2M | 88.7M | 95.4M | 95.8M | 93.3M | 82.2M | 76.0M | 87.8M |
| 應收帳款 | 34.4M | 44.6M | 42.6M | 47.8M | 67.4M | 71.5M | 66.6M | 66.2M | 60.1M | 51.1M | 51.7M | 51.6M |
| 存貨 | 7.0M | 26.4M | 26.7M | 28.3M | 27.9M | 22.9M | 19.3M | 19.2M | 20.1M | 19.5M | 18.0M | 18.8M |
| 總資產 | 533M | 411M | 413M | 432M | 444M | 490M | 477M | 467M | 452M | 467M | 501M | 515M |
| 有息負債 | – | – | – | – | – | – | 0.00 | 0.00 | – | – | – | – |
| 總負債 | 107M | 97.5M | 110M | 121M | 117M | 110M | 204M | 202M | 196M | 205M | 107M | 110M |
| 股東權益 | 426M | 314M | 303M | 311M | 327M | 379M | 273M | 265M | 256M | 261M | 394M | 405M |
| 負債比 | 20.1% | 23.7% | 26.7% | 28.0% | 26.3% | 22.5% | 42.7% | 43.3% | 43.4% | 44.0% | 21.4% | 21.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | 95.4M | 95.8M | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 4.3M-116% | – | – | – | −26.6M | – | – | −15.3M | – | – | – |
| 資本支出 | – | 3.8M | – | – | – | 1.6M | – | – | – | – | – | – |
| 自由現金流 | – | 514K-102% | – | – | – | −28.2M | – | – | – | – | – | – |
| 折舊攤銷 | – | 3.9M | – | – | – | 3.6M | – | – | 3.8M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | 0.00 | – | – | 522K | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 0.4% | – | – | – | -33.3% | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 380M
| Reportable | 380M | 100.0% | +13.8% |
|---|
地區2025 年度 · 380M
| 美國 | 360M | 94.8% | +13.3% |
|---|---|---|---|
| 美國以外 | 19.9M | 5.2% | +23.8% |
產品／服務2025 年度 · 380M
| 服務 | 274M | 72.3% | +10.1% |
|---|---|---|---|
| Patient And Digital Solutions | 56.9M | 15.0% | +30.5% |
| 產品 | 48.4M | 12.7% | +18.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 380M | +13.8% | −21.4M | -5.6% | -0.40 | – |
| FY2024 | 334M | +19.1% | 52.5M | 15.7% | 0.93 | – |
| FY2023 | 280M | -12.9% | −190M | -67.9% | -3.54 | – |
| FY2022 | 322M | +8.6% | −76.6M | -23.8% | -1.44 | – |
| FY2021 | 296M | +54.2% | −30.7M | -10.3% | -0.59 | – |
| FY2020 | 192M | +51.3% | −18.7M | -9.7% | -0.40 | – |
| FY2019 | 127M | +66.0% | −22.0M | -17.3% | -0.52 | – |
| FY2018 | 76.6M | – | −46.8M | -61.1% | -1.31 | −6.0M |